Sari L. Reisner

Sari L. Reisner

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Sari L. Reisner

Division of General Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA; Fenway Institute, Fenway Health, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in The Lancet
Verified
Journal Article
Closed access
SRSari L Reisner
Sari L Reisner
TPTonia Poteat
Tonia Poteat
JKJoAnne Keatley
JoAnne Keatley
MCMauro Cabral
Mauro Cabral
TMTampose Mothopeng
Tampose Mothopeng
SBStefan D Baral
Stefan D Baral

1 March 2015 in Journal of Adolescent Health
Verified
Journal Article
Closed access
SRSari L. Reisner
Sari L. Reisner
RVRalph Vetters
Ralph Vetters
MLM. Leclerc
M. Leclerc
SZShayne Zaslow
Shayne Zaslow
SWSarah Wolfrum
Sarah Wolfrum
MMMatthew J. Mimiaga
Matthew J. Mimiaga

15 August 2016 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Open access
SRSari L. ScD Reisner
Sari L. ScD Reisner
ARAsa Radix
Asa Radix
MDMadeline B. Deutsch
Madeline B. Deutsch
Transgender (trans) communities worldwide, particularly those on the trans feminine spectrum, are disproportionately burdened by HIV infection and at risk for HIV acquisition/transmission. Trans individuals represent an underserved, highly stigmatized, and under-resourced population not only in HIV prevention efforts but also in delivery of general primary medical and clinical care that is gender affirming. We offer a model of gender-affirmative integrated clinical care and community research to address and intervene on disparities in HIV infection for transgender people. We define trans terminology, briefly review the social epidemiology of HIV infection among trans individuals, highlight gender affirmation as a key social determinant of health, describe exemplar models of gender-affirmative clinical care in Boston MA, New York, NY, and San Francisco, CA, and offer suggested “best practices” for how to integrate clinical care and research for the field of HIV prevention. Holistic and culturally responsive HIV prevention interventions must be grounded in the lived realities the trans community faces to reduce disparities in HIV infection. HIV prevention interventions will be most effective if they use a structural approach and integrate primary concerns of transgender people (eg, gender-affirmative care and management of gender transition) alongside delivery of HIV-related services (eg, biobehavioral prevention, HIV testing, linkage to care, and treatment).

1 October 2016 in Journal of Counseling Psychology
Verified
Journal Article
Open access
SRSari L. Reisner
Sari L. Reisner
JHJaclyn M. White Hughto
Jaclyn M. White Hughto
KGKristi E. Gamarel
Kristi E. Gamarel
AKAlex S. Keuroghlian
Alex S. Keuroghlian
LMLauren Mizock
Lauren Mizock
JPJohn E. Pachankis
John E. Pachankis
Discrimination has been shown to disproportionately burden transgender people; however, there has been a lack of clinical attention to the mental health sequelae of discrimination, including posttraumatic stress disorder (PTSD) symptoms. Additionally, few studies contextualize discrimination alongside other traumatic stressors in predicting PTSD symptomatology. The current study sought to fill these gaps. A community-based sample of 412 transgender adults (mean age 33, SD = 13; 63% female-to-male spectrum; 19% people of color; 88% sampled online) completed a cross-sectional self-report survey of everyday discrimination experiences and PTSD symptoms. Multivariable linear regression models examined the association between self-reported everyday discrimination experiences, number of attributed domains of discrimination, and PTSD symptoms, adjusting for prior trauma, sociodemographics, and psychosocial comorbidity. The mean number of discrimination attributions endorsed was 4.8 (SD = 2.4) and the 5 most frequently reported reasons for discrimination were: gender identity and/or expression (83%), masculine and feminine appearance (79%), sexual orientation (68%), sex (57%), and age (44%). Higher everyday discrimination scores (β = 0.25; 95% CL [0.21, 0.30]) and greater number of attributed reasons for discrimination experiences (β = 0.05; 95% CL [0.01, 0.10]) were independently associated with PTSD symptoms, even after adjusting for prior trauma experiences. Everyday discrimination experiences from multiple sources necessitate clinical consideration in treatment for PTSD symptoms in transgender people. (PsycINFO Database Record

27 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SRSari L Reisner
Sari L Reisner
JHJaclyn M W Hughto
Jaclyn M W Hughto
In the U.S., non-binary refers to transgender people who have a gender identity not aligned with their assigned sex at birth, and who identify outside of the traditional male-female binary, such as genderqueer, genderfluid, or gender nonconforming. Few data are available to characterize the health of non-binary adults. The current study sought to fill this gap by conducting a secondary analysis of data from a non-probability sample of transgender and/or gender nonconforming adults in Massachusetts (sample mean age 32.6 years, 63% female assigned sex at birth; 79.4% white non-Hispanic/Latinx). Multivariable models were fit to compare non-binary (e.g., genderqueer) vs. binary (e.g., man/trans man, woman/trans woman) respondents across a range of social and health indicators. Overall, 40.9% identified their gender identity as non-binary. Non-binary respondents significantly differed from binary respondents on (all p<0.05): demographics (younger age, more female assigned sex at birth); gender affirmation (older age of identity recognition, lower current uptake of and future desires for medical gender affirmation); healthcare utilization (lower rates of being up-to-date in annual wellness visit, less mental healthcare utilization in past year); mental health and substance use (higher past-week depressive distress, higher hazardous alcohol use); social history (more unstably housed, more current students), violence victimization (lower rates of lifetime intimate partner violence), and social support (less family support). Gender diversity, including whether people endorse a binary or non-binary gender identity, is a prevalent and an important aspect of transgender health. Demographic measures of gender identity that include binary and non-binary response options are recommended to inform future research and clinical care.

29 July 2015 in The Milbank Quarterly
Verified
Journal Article
Closed access
PDF file
SRSari L. Reisner
Sari L. Reisner
JHJaclyn M. White Hughto
Jaclyn M. White Hughto
EDEmilia E. Dunham
Emilia E. Dunham
KHKatherine J. Heflin
Katherine J. Heflin
JBJesse Blue Glass Begenyi
Jesse Blue Glass Begenyi
SCSean Cahill
Sean Cahill